A detailed history of Mendota Financial Group, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Mendota Financial Group, LLC holds 953 shares of EXAS stock, worth $41,141. This represents 0.04% of its overall portfolio holdings.

Number of Shares
953
Previous 953 -0.0%
Holding current value
$41,141
Previous $70.5 Million 6.65%
% of portfolio
0.04%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

BUY
$59.06 - $75.72 $48,724 - $62,469
825 Added 644.53%
953 $70.5 Million
Q3 2023

Oct 12, 2023

BUY
$65.94 - $99.04 $659 - $990
10 Added 8.47%
128 $8.73 Million
Q4 2022

Feb 03, 2023

BUY
$30.35 - $53.15 $3,581 - $6,271
118 New
118 $5.84 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.